Advertisement

Topics

Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials

11:23 EDT 14 Sep 2018 | Xconomy

Allogene Therapeutics, a biotech developing a cell therapy made from donor cells, is laying out IPO plans to finance more tests of its experimental cancer treatment. South San Francisco, CA-based Allogene made waves this year when it launched with a huge $300 million Series A round. It has now set a preliminary $100 million IPO […]

Original Article: Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials

NEXT ARTICLE

More From BioPortfolio on "Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...